Transforming Biotherapeutic Delivery with Non-Thermal Electrohydrodynamic Technologies: New Data

Session details:

• Enhancing the stability of biotherapeutics through controlled dehydration. Learn how non-thermal electrohydrodynamic technologies generate dry biotherapeutic formulations with tightly controlled particle size distributions (PSD), preserving biological activity while improving stability, reducing cold-chain dependence, and extending product shelf life.
• Enabling next-generation patient-centric dosage forms. Discover how controlled particle engineering facilitates high-concentration formulations and alternative routes of administration—including sublingual, pulmonary, and intranasal delivery—creating opportunities to improve patient adherence and expand therapeutic applications.
• Advancing needle-free vaccination and decentralized healthcare. Explore how stable vaccine dehydrated powders and patches produced by electrohydrodynamic technologies can enable needle-free administration, simplify distribution through reduced temperature-control requirements, and improve global access to vaccination.